Postbariatric Hypoglycemia
Postbariatric hypoglycemia is a condition that occurs in some individuals after weight loss surgery, leading to episodes of low blood sugar (hypoglycemia) that can cause symptoms like dizziness, sweating, and confusion.
Sotagliflozin for Post-Bariatric Hypoglycaemia
We are studying whether sotagliflozin can help people who have low blood sugar after weight loss surgery. Participants will receive either the medication or a placebo to compare effects on blood sugar levels.
≤3 months≤5 visitsEfficacy phase (II)Cost ReimbursementInvestigational MedicinesOralEndocrinologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 74 years old?
- Do you have a history of low blood sugar (hypoglycemia) after meals that improves with eating?
- Have you had any major surgery in the past 30 days?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that affect insulin or blood sugar, like Metformin or insulin?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sotagliflozin
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Steno Diabetes Center Copenhagen
Clinical Research
Rødovre, Denmark
Sponsor: Steno Diabetes Center Copenhagen
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.